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In recent years, green synthesis of nanoparticles, i.e., synthesizing nanoparticles using biological sources like
bacteria, algae, fungus, or plant extracts have attracted much attention due to its environment-friendly and
economic aspects. The present study demonstrates an eco-friendly and low-cost method of biosynthesis of
silver nanoparticles using cell-free filtrate of phytopathogenic fungus Macrophomina phaseolina. UV-visible
spectrum showed a peak at 450 nm corresponding to the plasmon absorbance of silver nanoparticles. Scanning
electron microscopy (SEM), atomic force microscopy (AFM), and transmission electron microscopy (TEM) revealed the
presence of spherical silver nanoparticles of the size range 5 to 40 nm, most of these being 16 to 20 nm in diameter.
X-ray diffraction (XRD) spectrum of the nanoparticles exhibited 2θ values corresponding to silver nanoparticles.
These nanoparticles were found to be naturally protein coated. SDS-PAGE analysis showed the presence of an
85-kDa protein band responsible for capping and stabilization of the silver nanoparticles. Antimicrobial activities
of the silver nanoparticles against human as well as plant pathogenic multidrug-resistant bacteria were assayed.
The particles showed inhibitory effect on the growth kinetics of human and plant bacteria. Furthermore, the
genotoxic potential of the silver nanoparticles with increasing concentrations was evaluated by DNA fragmentation
studies using plasmid DNA.
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The production, manipulation, and application of nano-
scale particles, usually ranging from 1 to 100 nanometers
(nm), is an emerging area of science and technology
today [1]. Synthesis of noble metal nanoparticles for ap-
plications in catalysis, electronics, optics, environmental
science, and biotechnology is an area of constant interest
[2]. Generally, metal nanoparticles can be prepared and
stabilized by physical and chemical methods. Studies
have shown that the size, morphology, stability, and* Correspondence: surekha_kundu@yahoo.com
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reproduction in any medium, provided the origphysicochemical properties of the metal nanoparticles
are strongly influenced by the experimental conditions,
the kinetics of interaction of metal ions with reducing
agents, and adsorption processes of stabilizing agent
with metal nanoparticles [3]. Chemical approaches, such
as chemical reduction, electrochemical techniques, and
photochemical reduction, are most widely used [2]. Re-
cently, different solvothermal [4] and hydrothermal [5]
approaches are employed for inorganic synthesis of
nanoparticles. Chemical reduction is the most fre-
quently applied method for the preparation of silver
nanoparticles as stable, colloidal dispersions in water
or organic solvents [6]. However, several harmful chemical
by-products, metallic aerosol, irradiation, etc. are commonlyis is an open access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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with the facts that these processes are expensive, time con-
suming, and typically done on small laboratory scale, render
these methods less suitable for large-scale production [7-9].
The approach for production of nanoparticles therefore
should be nontoxic, environmentally harmless, as well as
cost effective [1].
For green synthesis of nanoparticles, bio-extracts from
diverse group of microorganisms act as a reducing and
sometimes as a capping agent in nanoparticle synthesis,
ranging from algae [10] to bacteria [11] and also from
fungi [12]. For large-scale synthesis of nanoparticles in
bioreactors, filamentous fungi are better agents for bio-
mass production in comparison to algae and bacteria,
since fungal mycelial mat can withstand flow pressure,
agitation, and other conditions in the bioreactors [12].
Extracellular secretion of reductive proteins aids in extra-
cellular synthesis of silver nanoparticles avoiding unneces-
sary cellular interference, and therefore, it is suitable for
direct use in various applications. There are reports of
mycosynthesis of silver nanoparticles using phytopatho-
genic fungi like Fusarium acuminatum [13], Aspergillus
flavus [14], Alternaria alternata [15], Coriolus versicolor
[16], Penicillium fellutanum [17], and Fusarium semitec-
tum [18]. Some fungi investigated were found to be
capable of both extra- and intracellular biosynthesis of
Ag-NPs having different particle sizes and shapes, but
extracellular production of nanoparticles is more desir-
able from the point of view of easy isolation.
Nanoparticles have some unique size- and shape-
dependent physical and optical properties [19]. These
unique characters are often responsible for their tox-
icity to various kinds of microbes such as bacteria,
fungi, and also cancerous cells [20-22]. Hence, studies
are going on regarding their utility in the diagnosis as
well as treatment of different kinds of diseases [23,24].
In this regard, the presence of protein capping material
is advantageous because this acts as the anchoring
layer for drug or genetic materials to be transported
into human cells [25]. The presence of a nontoxic pro-
tein cap also increases uptake and retention inside hu-
man cells [26].
The present study deals with the extracellular biosyn-
thesis of silver nanoparticles, using cell-free extract of
phytopathogenic soil-borne fungus Macrophomina pha-
seolina (Tassi) Goid, the causal organism of charcoal rot
disease of about 500 agronomical important crops all
over the world [27]. It describes not only a new method
of green synthesis of silver nanoparticles but also their
physical attributes, antibacterial activity against human
and plant pathogenic multidrug-resistant bacteria, the
inhibitory effect on the growth kinetics of microbes, the
capping material around the silver nanoparticles, as well
as their genotoxic effect.Methods
M. phaseolina was grown in PDA medium at 28°C and
was used for the synthesis of silver nanoparticles. The
mycelium from solid substrate was inoculated in 50 ml
potato dextrose broth (PDB) in 250-ml Erlenmeyer flasks
and incubated at 28°C for 5 days. The fully expanded my-
celial mat was harvested aseptically and washed with ster-
ile distilled water to remove media components. One
gram of washed mat was added to 10 ml of deionized
water in a 250-ml Erlenmeyer flask and agitated at 28°C
for 72 h in an orbital shaker at 120 rpm. The extract was
collected and filtered through Whatman filter paper No. 1
(Whatman, Piscataway, NJ, USA). This cell-free filtrate
was used for nanoparticle synthesis. The biosynthesis of
silver nanoparticles was done by adding silver nitrate
(AgNO3) solution to 50-ml cell filtrate to a final concen-
tration of 1 mM in a 250-ml Erlenmeyer flask and agitat-
ing in a shaker at 120 rpm at 28°C in the dark for 24, 48,
and 72 h. A control set without silver nitrate was simul-
taneously agitated with experimental set [26]. The silver
nanoparticle synthesis was visible by distinct change in
coloration of cell filtrate.
The qualitative testing for confirmation of silver nano-
particles was done with UV–vis spectroscopy. One milli-
liter of sample aliquot from this bio-transformed product
was drawn after 24, 48, and 72 h postincubation with sil-
ver nitrate solution, and absorbance was recorded by
using Hitachi U-2000 spectrophotometer (Hitachi, Ltd.,
Chiyoda-ku, Japan) range between 350 and 600 nm in
order to study the change in light absorption of the solu-
tion with increase in color intensity.
About 20 μl of silver nanoparticle solution was spread
as a thin film on a glass stub (1 cm × 1 cm) and was vac-
uum dried. The sample was subjected to scanning elec-
tron microscopy using FEI Quanta 200 (FEI, Hillsboro,
OR, USA). The average size and shapes of the silver
nanoparticles were determined by transmission electron
microscopy (TEM). A drop of nanoparticles suspension
was placed on a carbon-coated copper grid and was
dried under vacuum. Micrographs were obtained in a
JEOL JEM 2100 HR transmission electron microscope
(JEOL Ltd., Akishima-shi, Japan) with 80- to 200-kV ac-
celerating voltage at 0.23-nm resolution. For atomic
force microscopy (AFM) imaging of silver nanoparticles,
10 μl of the nanoparticle suspension was deposited onto
a freshly cleaved muscovite Ruby mica sheet (Ruby Mica
Co. Ltd., Jharkhand, India) and left to stand for 15 to
30 min. The sample was subsequently dried by using a
vacuum dryer and washed with 0.5 ml Milli-Q water
(Millipore, Billerica, MA, USA). The sheets were dried
again by a vacuum dryer. The size and topography of sil-
ver nanoparticles were investigated using atomic force
microscope (Model Innova, Bruker AXS Pvt. Ltd, Madison,
WI, USA) under tapping mode in which high-resolution
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tilevers of 135-μm length and 8-nm diameter with a nom-
inal spring force constant of 20 to 80 N/m were used. The
cantilever resonance frequency was 276 to 318 kHz. The
deflection signal is analyzed in the NanoScope IIIa control-
ler (Bruker AXS Pvt. Ltd.), and the images (512 ×
512 pixels) were captured with a scan size range of 0.5 and
5 μm.
For X-ray diffraction (XRD) of silver nanoparticles, a
thin film of nanoparticle solution was spread evenly on a
glass slide and dried by using vacuum dryer. XRD pat-
terns were recorded in a D8 Advance DAVINCI XRD
System (Bruker AXS Pvt. Ltd.) operated at a voltage of
40 kV and a current of 40 mA with CuKα radiation (λ =
1.54060/1.54443 Å), and the diffracted intensities were
recorded from 35° to 80° 2θ angles.
The multidrug-resistant strains of Escherichia coli
(DH5α) and Agrobacterium tumefaciens (LBA4404) were
prepared according to previous report from our lab [28].
The DH5α-multidrug-resistant (MDR) strain (containing
plasmids pUC19 and pZPY112) was selected against an-
tibiotics ampicillin (100 μg/ml) and chloramphenicol
(35 μg/ml). LBA4404-MDR containing plasmid pCAM-
BIA 2301 was selected against antibiotics rifampicin
(25 mg/l) and kanamycin (50 mg/l). LB broth/agar were
used to culture the bacteria. The disc diffusion method
was employed for assaying antimicrobial activities of bio-
synthesized silver nanoparticles against E. coli (DH5α),
multidrug-resistant E. coli (DH5α-MDR), plant pathogenic
bacteria A. tumefaciens (LBA4404), and multidrug-resistant
A. tumefaciens (LBA4404-MDR). One hundred microliters
of overnight cultures of each bacterium was spread onto
LB agar plates. Concentration of nanoparticles in suspen-
sion was calculated according to [27] following the formula
c ¼ TNVA [where C =molar concentration of the nanoparti-
cles solution, T = total number of silver atoms added as
AgNO3 (1 mM), N = number of atoms per nanoparticles,
V = volume of reaction solution in liters, and A = Avo-
gadro’s number (6.023 × 1,023)]. The concentration of
silver nanoparticles was found to be 51 mg/l. This sil-
ver nanoparticle suspension was used in requisite amount
for further antimicrobial study. Sterile paper discs of
5-mm diameter with increasing percentage of silver
nanoparticles in a total volume of 100 μl (volume made
up with sterile double distilled water) were placed on each
plate. Ten, 20, 50, 70, and 100% silver nanoparticle solu-
tion corresponding to 0.51, 1.02, 2.55, 3.57, and 5.1 μg of
silver nanoparticles in 100-μl solution each were placed
on the discs. Plates inoculated with A. tumefaciens
(LBA4404 and LBA4404-MDR) were incubated in 28°C
for 48 h, and those inoculated with strains of E. coli
(DH5α and DH5α-MDR) were kept at 37°C for 12 h. Anti-
microbial activity of silver nanoparticles was assessed by
measuring inhibition zones around the discs.In order to observe the effect of the silver nanoparti-
cles on growth kinetics of bacteria, silver nanoparticles
were added to the liquid culture of two bacteria, E. coli
(DH5α) and A. tumefaciens (LBA4404). For the initial
culture, 7 ml of LB medium was inoculated with 500 μl
of overnight grown bacterial culture. This freshly set
bacterial culture was supplemented with 2.5 ml of nano-
particle suspension, with concentration of 51 μg/ml. In
each of the control sets, 2.5 ml of Macrophomina cell fil-
trate only was added without nanoparticles. The OD
values of the mixture was recorded at 600-nm wave-
length of visible light at regular time intervals (i.e., 0, 2,
4, 6, 8, 12, and 24 h postinoculation) to plot the growth
curves of each of the nanoparticle-treated bacterial cul-
tures and was compared with that of the untreated
control.
For isolation of extracellular proteins, about 500 mg of
fungal mycelial mat was taken in a microcentrifuge tube,
and 500 μl of sterile deionized water was added. The
mixture was inverted two to three times for even disper-
sion of fungal tissue in water. The mixture was gently
agitated overnight at 4°C on a shaker. The next day, the
slurry was centrifuged at 10,000 rpm for 10 min at 4°C.
The cell-free filtrate containing the extracellular proteins
was analyzed by one-dimensional SDS-PAGE. In order
to isolate the protein(s) bound to the surface of silver
nanoparticles, the particles were washed with sterile dis-
tilled water and boiled with 1% sodium dodecyl sulfate
(SDS) solution for 10 min followed by centrifugation at
8,000 rpm for 10 min for collection of supernatant. The
untreated nanoparticles (without boiling in 1% SDS solu-
tion) were kept as control. All the other samples were
denatured in 2× Laemmli’s sample buffer and boiled for
5 to 10 min, followed by centrifugation at 8,000 rpm at
4°C for 3 min. Electrophoresis was performed in a 12%
SDS-polyacrylamide gel using Bio-Rad Mini-PROTEAN
gel system (Bio-Rad, Hercules, CA, USA) at a constant
voltage of 100 kV for 2 h. Postelectrophoresis, gel was
stained with Coomassie Brilliant Blue dye and observed
in a gel-imaging system (Chromous Biotech, Bangalore,
India).
Genotoxic potential of the silver nanoparticles was tested
against plasmid pZPY112 according to [29,30], with minor
modifications. Plasmid was isolated from DH5α (containing
pZPY112 vector, selected against rifampicin 50 mg/l and
chloramphenicol 40 mg/l) by alkaline lysis method. Five
micrograms of plasmid was incubated with 0.51, 1.02, 2.55,
3.57, and 5.1 μg of silver nanoparticle (in a total volume of
100 μl solution) in 1 mM Tris (pH = 7.8) for a period of 2 h
at 37°C. In control set, cell filtrate was used instead of the
nanoparticle solution. Products were run on a 1.5% agarose
gel in 1× TAE buffer at 100 V for 45 min and visualized by
ethidium bromide staining. Photographs were taken in an
UV-transilluminator (Biostep, Jahnsdorf, Germany).
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particles against bacteria, each bar represents mean of
three experiments ± standard error of mean (SEM). Dif-
ferences between treatments (concentration of nanopar-
ticles) in antimicrobial assay were tested using one-way
ANOVA (GraphPad Prism, version 5, La Jolla, CA,
USA) followed by Tukey’s honestly significant differ-
ence (HSD) test, for differences that were significant at
5% probability.
Results and discussion
Biosynthesis of silver nanoparticles from cell-free filtrate
of Macrophomina phaseolina
The cell-free filtrate of M. phaseolina was used for the
biosynthesis of the silver nanoparticles as described in
methods. Figure 1a shows that AgNO3 solution itself is
colorless (tube 1). The fungal cell filtrate incubated with-
out AgNO3 (tube 2) was also almost colorless. The fungal
cell filtrate, after incubation with 1 mM AgNO3 (tube 3),
underwent a distinct change in its color to brown within
24 h, which indicated the formation of silver nanoparticles
due to the conversion of Ag+ ions to elemental Ag by
extracellular reductase activity of M. phaseolina filtrate.
The color intensity of the silver nanoparticle solution per-
sisted even after 72 h, which indicated that the particles
were well dispersed and stable in the solution. The myco-
synthesis of silver nanoparticles involves trapping of Ag +
ions at the surface of the fungal cells and the subsequent
reduction of the silver ions by the extracellular enzymes
like naphthoquinones and anthraquinones present in the
fungal system. One earlier study with Fusarium oxy-
sporum shows that NADPH-dependent nitrate reductase
and shuttle quinine extracellular process are responsible
for nanoparticle formation [31]. Extracellular secretion of
enzymes is especially advantageous for large-scale nano-
particle synthesis since large quantities of relatively pure
enzyme can be obtained, free from other cellular proteins1 2 3
a b
Figure 1 Synthesis of silver nanoparticles using cell-free filtrate of Ma
of 1 mM AgNO3 solution without cell filtrate (1, control), mycelia-free cell fi
incubation at 28°C (3). (b) UV–vis spectra recorded as a function of time of
1 mM AgNO3 with the M. phaseolina cell filtrate showing absorption peakassociated with the organism. The nanoparticles thus pro-
duced can be easily isolated by filtering from the reaction
mix [28].
UV–vis spectroscopy of the silver nanoparticles
The silver nanoparticles were subjected to spectral ana-
lysis by UV–vis spectroscopy. The absorption spectra of
nanoparticles showed symmetric single-band absorption
with peak maximum at 450 nm for 24, 48, and 72 h of
incubation of cell filtrate with AgNO3 which steadily in-
creased in intensity as a function of time of reaction
without any shift in the peak (Figure 1b). This indicates
the presence of silver nanoparticles, showing the longi-
tudinal excitation of surface plasmon, typical of silver
nanoparticles.
Morphological study of the silver nanoparticles with
scanning electron microscopy
The morphology (viz shape and size) of the silver nano-
particles studied under scanning electron microscopy
(SEM) (magnification × 50,000) revealed that the nano-
particles were mostly spherical in shape and polydisperse
in nature (Figure 2a). The nanoparticles were not in direct
contact even within the aggregates, indicating stabilization
of the nanoparticles by a capping agent.
Transmission electron microscopy study of silver
nanoparticles
Transmission electron microscopy (TEM) micrographs
showed that particles are spherical, uniformly distributed
without any significant aggregation (Figure 2b,c,d). Some
of the nanoparticles showed striations (Figure 2d). The
particle size histogram of silver nanoparticles showed
that particle size ranges from 3.33 to 40.15 nm with an
average size of 17.26 ± 1.87 nm. Frequency distribution
observed from histogram showed that majority of parti-






















crophomina phaseolina and spectroscopic analysis. (a) Photograph
ltrate of M. phaseolina (2), and 1 mM AgNO3 with cell filtrate after 24-h


























Figure 2 Electron micrographs of silver nanoparticles. (a) Scanning electron microscopy micrograph of silver nanoparticles produced
with M. phaseolina at 50,000 magnification (bar = 1 μm). (b, c, d) Transmission electron micrograph of silver nanoparticles at different
magnifications (bar = 100 nm). (e) Measurement of nanoparticles of different shapes. (f) Histogram showing particle size distribution of silver
nanoparticles with majority of the particles showing 16 to 20 nm size range.
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small and polydisperse in nature. This small size range
of silver nanoparticles adds to its antibacterial property,
since it can easily penetrate bacterial cell membrane and
thereafter damage the respiratory chain, affect the DNA,
RNA, and division of the cell, and finally lead to cell
death [32].
Morphological study using atomic force microscopy
The shape and size of the silver nanoparticles were fur-
ther confirmed by atomic force microscopy (AFM). Ma-
jority of the particles were symmetrical and spherical in
shape and mostly dispersed; although in some places,
nanoparticles were found to be in aggregates (Figure S1in Additional file 1). The graph depicting the profile of
the particles under AFM shows most particles were less
than 50 nm in height (Figure S1 in Additional file 1).
X-ray diffraction analysis of silver nanoparticles
Due to the crystalline nature of silver nanoparticles, in-
tense X-ray diffraction (XRD) peaks were observed cor-
responding to the (111), (200), (220), and (311) planes
for silver at 2θ angles of 38.21°, 47°, 65.27°, and 77.6°, re-
spectively (Figure 3). This was in agreement with the
unit cell of the face-centered cubic (fcc) structures
(JCPDS file no. 04–0783) with a lattice parameter of a =
4.077 A0. The exact nature of silver particles formed
posttreatment of cell-free filtrate with silver nitrate was









































































Figure 4 Antimicrobial effect of silver nanoparticles against normal and multidrug-resistant human bacteria E. coli by disc diffusion
method. (a) Plate showing increasing inhibition zone of E. coli (DH5α) with increasing concentration of nanoparticles: clockwise from top 0.51,
1.02, 2.55, 3.57, and 5.1 μg in a total volume 100 μl in water. (b) Plate showing increasing inhibition zone of MDR E. coli (DH5α-MDR) with
increasing concentration of nanoparticles: clockwise from top 0.51, 1.02, 2.55, 3.57, and 5.1 μg in a total volume 100 μl in water. (c) Graph of
antimicrobial assay of the nanoparticles on E. coli (DH5α ) in which 10, 20, 50, 70, and 100% nanoparticle solution corresponds to 0.51, 1.02, 2.55,
3.57, and 5.1 μg of silver nanoparticles in 100 μl solution, respectively. (d) Graph of antimicrobial assay of the silver nanoparticles on MDR E. coli
(DH5α-MDR). Vertical bars indicate mean of three experiments ± standard error of mean (SEM). Different letters on bars indicate significant
differences among treatments (P = 0.05).
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crystalline silver structures and pure silver nitrate have
been published by the Joint Committee on Powder Dif-
fraction Standards (file nos. 04–0783 and 84–0713). A
comparison of our XRD spectrum with the standard
confirmed that the silver particles formed in our experi-
ment were in the form of nanocrystals. The XRD spectrum
in the present study agrees with Bragg’s reflection of silver
nanocrystals, similar reported in other literature [15].
Antimicrobial activity of silver nanoparticles against human
and plant pathogenic bacteria and multidrug-resistant
bacteria
The human bacteria E. coli and the plant pathogenic
bacteria A. tumefaciens were used to assay the anti-
microbial activity of the silver nanoparticles. The normal
E. coli (Figure 4a) as well as the MDR E. coli (Figure 4b)
plates showed inhibition zones which increased with the
increase in concentration of nanoparticles. The graphs


























Figure 5 Antimicrobial effect of silver nanoparticles on normal and m
disc diffusion method. (a) Plate showing increasing inhibition zone of A.
clockwise from top 0.51, 1.02, 2.55, 3.57, and 5.1 μg in a total a volume 100
tumefaciens (LBA4404-MDR) with increasing concentration of nanoparticles
of 100 μl in water. (c) Graph of antimicrobial assay of the nanoparticles on
nanoparticle solution corresponds to 0.51, 1.02, 2.55, 3.57, and 5.1 μg of silv
the silver nanoparticles on MDR A. tumefaciens (LBA4404-MDR). Vertical bar
Different letters on bars indicate significant differences among treatmentsactivity of the nanoparticles against the normal and the
MDR E. coli (Figure 4c,d). Similarly, normal and MDR
A. tumefaciens plates showed increase in inhibition
zones in response to increase in nanoparticle concentra-
tion (Figure 5a,b). The graphs of inhibition zone as a
function of increasing concentration of nanoparticles
(Figure 5c,d) showed similar trend with that of the E. coli.
In general, A. tumefaciens (both LBA4404 and LBA4404
MDR) showed greater sensitivity to the silver nanoparti-
cles than E. coli (DH5α) and multidrug-resistant E. coli
(DH5α-MDR).
All the four microbes tested (DH5α, DH5α-MDR,
LBA4404, LBA4404-MDR) against silver nanoparticles
were inhibited significantly (P = 0.05) in a dose-dependent
manner. The antimicrobial activity exhibited by silver
nanoparticles is shown in the graph of inhibition zone of
four bacteria as a function of increasing concentration of
nanoparticles (Figures 4 and 5). In general, both E. coli
(DH5α) and multidrug-resistant E. coli (DH5α-MDR)




























ultidrug-resistant plant pathogenic bacteria A. tumefaciens by
tumefaciens (LBA4404) with increasing concentrations of nanoparticles:
μl in water. (b) Plate showing increasing inhibition zone of MDR A.
: clockwise from top 0.51, 1.02, 2.55, 3.57, and 5.1 μg in a total volume
A. tumefaciens (LBA4404) in which 10, 20, 50, 70, and 100%
er nanoparticles in 100 μl solution. (d) Graph of antimicrobial assay of










































Figure 6 Inhibitory effect of silver nanoparticles on the growth
kinetics of human and plant pathogenic bacteria. (a) Absorbance
data for bacterial growth of plant pathogenic bacteria (Agrobacterium
tumefaciens) LBA4404 without or with the nanoparticles for 0, 4, 6, 8, 12,
and 24 h postinoculation. (b) Absorbance data for bacterial growth of
human pathogenic bacteria (E. coli) DH5α without or with nanoparticles
for 0, 4, 6, 8, 12, and 24 h postinoculation showing significant inhibitory
effect on the growth kinetics of the bacteria.
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though, the exact mechanism by which silver nanoparti-
cles act as antimicrobial agent is not fully understood,
there are several theories. Silver nanoparticles can anchor
onto bacterial cell wall and, with subsequent penetration,
perforate the cell membrane (pitting of cell membrane) ul-
timately leading to cell death [33]. The dissipation of the
proton motive force of the membrane in E. coli occurs
when nanomoles concentration of silver nanoparticles is
given [34]. Earlier studies with electron spin resonance
spectroscopy revealed that free radicals are produced by
silver nanoparticles in contact with bacteria, which dam-
age cell membrane by making it porous, ultimately leading
to cell death [31]. Antimicrobial activities of silver nano-
particles from other fungal sources like F. semitectum [18]
and Aspergillus niger [35] gave similar observations. A
previous study from our laboratory [28] reported simi-
lar antimicrobial activities of silver nanoparticles from
Tricholoma crassum against human and plant patho-
genic bacteria.
Effect of the silver nanoparticles on the kinetics of
microbial growth
The growth kinetics of the bacteria E. coli DH5α (Figure 6a)
and A. tumefaciens LBA4404 (Figure 6b) were clearly sup-
pressed by the addition of the nanoparticles. Growth of
both E. coli and A. tumefaciens showed inhibition of
growth within 4 h postinoculation with less optical density
readings at all subsequent time points compared to the
control. This has been attributed to the reduced growth
rate of bacterial cells due to antimicrobial activity of silver
nanoparticles.
Analysis of capping protein around the silver
nanoparticles
Sometimes during the biosynthesis process, after the pro-
duction of silver nanoparticles, reaction is followed by
stabilization of nanoparticles by capping agents (i.e., extra-
cellular proteins) from fungal mycelia [16]. To characterize
the extracellular fungal proteins associated with the silver
nanoparticles, SDS-PAGE was used. Cell filtrate (CF) was
isolated by centrifugation from mycelial mat slurry. Protein
profiles of cell filtrate clearly showed the presence of sev-
eral bands of molecular weights between 50 and over
116 kDa (Figure 7, lane 2). Some of these proteins may be
responsible for synthesis as well as stability of the silver
nanoparticles. Treatment of silver nanoparticles with 1%
SDS in boiling water bath for 10 min resulted in detach-
ment of the capping protein(s) from the nanoparticles.
When analyzed by SDS-PAGE, the boiled sample showed
an intense band of 85 kDa (Figure 7, lane 4) which was not
seen when the nanoparticles were not boiled with sample
buffer (Figure 7, lane 3). This band is similar to the protein
band present in the cell filtrate (Figure 7, lane 2). It is likelythat this 85-kDa protein acts as a capping material and
confers stability to the silver nanoparticles. Detection of
extracellular proteins responsible for synthesis and stability
of silver nanoparticles were also reported from a few other
literatures [14,36]. The presence of natural capping pro-
teins eliminates the postproduction steps of capping which
is necessary for most of applications of nanoparticles in the
field of medicine.
Genotoxic effect of silver nanoparticles against plasmid
DNA
Agarose gel electrophoresis of plasmid pZPY112 treated
with different concentrations of silver nanoparticles showed
a dose-dependent induction of DNA strand break, charac-
terized by increased degradation of supercoiled form to re-
laxed circle to linear forms with increase in concentration
of nanoparticles used (Figure 8). DNA strand scission in-
duced by silver nanoparticle leads to gradual degradation in










Figure 8 Agarose gel electrophoresis of plasmid pZPY112 treated wit
Lane 1, DNA molecular weight marker. Lane 2, control plasmid without silv
ahead of relaxed circular and linear plasmids. Lane 3, plasmid incubated w
plasmid band and appearance of relaxed circular and linear plasmid bands
1.02 μg nanoparticles. Lane 5, plasmid incubated with 2.55 μg nanoparticle













Figure 7 SDS-PAGE analysis of capping protein around the
silver nanoparticles. Lane 1, molecular size marker; lane 2,
extracellular proteins in the cell filtrate; lane 3, nanoparticles loaded
without boiling show no protein band; and lane 4, nanoparticles
after boiling with 1% SDS loading buffer show a major 85-kDa
capping protein.
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resultant fragmented DNA (Figure 8). Besides their anti-
microbial activity, silver nanoparticles have been shown to
be potentially genotoxic by in vivo and in vitro assays [37].
In the present study, the genotoxicity exhibited by silver
nanoparticles was demonstrated by degradation of plasmid
posttreatment even with low concentrations of the nano-
particles. Such genotoxic activities of nanoparticles were re-
ported earlier in case of carbon nanotubes [38] where
degree of DNA degradation was directly proportional to
the concentration of nanoparticles. A proposed mechanism
of DNA damage is through generation of singlet oxygen as
reported in the case of copper nanoparticles [30].
Conclusions
In this study, phytopathogenic fungus M. phaseolina
(Tassi) Goid was used for the first time for the extracel-
lular biosynthesis of silver nanoparticles by bioreduction
of aqueous Ag + ion. SEM, TEM, and AFM were used
to study the morphology, concentration, and size of
biosynthesized nanoparticles. The silver nanoparticles
exhibited distinct antimicrobial property on multidrug-
resistant human and plant pathogenic bacteria. An 85-
kDa protein present in the extracellular solution was
responsible for synthesis and capping of nanoparticles.
This eco-friendly, cost-effective extracellular biosyn-
thesis of naturally protein-capped silver nanoparticles with






h different concentrations of the silver nanoparticles (μg/100 μl).
er nanoparticles showing only supercoiled plasmid band that moves
ith 0.51 μg nanoparticles showing disappearance of the supercoiled
along with smaller fragmented DNA. Lane 4, plasmid incubated with
s. Lane 6, plasmid incubated with 3.57 μg nanoparticles showing
cubated with 5.1 μg nanoparticles showing more degradation of DNA.
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